VERTEX

Serial Number 73839157
Registration 1630448
800

Registration Progress

Application Filed
Nov 14, 1989
Under Examination
Approved for Publication
Sep 8, 1990
Published for Opposition
Oct 9, 1990
Registered
Jan 1, 1991

Basic Information

Serial Number
73839157
Registration Number
1630448
Filing Date
November 14, 1989
Registration Date
January 1, 1991
Published for Opposition
October 9, 1990
Renewal Date
January 1, 2021
Drawing Code
1

Status Summary

Current Status
Active
Status Code
800
Status Date
Sep 4, 2020
Registration
Registered
Classes
042

Rights Holder

VERTEX PHARMACEUTICALS INCORPORATED

03
Address
50 Northern Avenue
Boston, MA 02210

Ownership History

VERTEX PHARMACEUTICALS INCORPORATED

Original Applicant
03
CAMBRIDGE, MA

VERTEX PHARMACEUTICALS INCORPORATED

Owner at Publication
03
CAMBRIDGE, MA

VERTEX PHARMACEUTICALS INCORPORATED

Original Registrant
03
Boston, MA

Legal Representation

Attorney
Steven A. Abreu
USPTO Deadlines 1 active
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
MAINTENANCE
Section 8 & 9 (40-Year) Renewal Due (Based on registration date 1991-01-01)
R.PRA Jan 01, 2031 2004 days Critical No
Next deadline: Section 8 & 9 (40-Year) Renewal Due (Based on registration date 1991-01-01) on January 01, 2031 (2004 days)

Application History

27 events
Date Code Type Description
Sep 4, 2020 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sep 4, 2020 RNL3 Q REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
Sep 4, 2020 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sep 4, 2020 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 30, 2020 E89R I TEAS SECTION 8 & 9 RECEIVED
Feb 10, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 1, 2020 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 14, 2014 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 14, 2014 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 23, 2010 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Nov 23, 2010 RNL2 Q REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Nov 18, 2010 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 9, 2010 E89R I TEAS SECTION 8 & 9 RECEIVED
Nov 24, 2009 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 6, 2009 CFIT O CASE FILE IN TICRS
Apr 21, 2001 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Apr 21, 2001 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jan 2, 2001 89AF I REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Feb 1, 1997 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 6, 1997 815F I REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Jan 1, 1991 R.PR A REGISTERED-PRINCIPAL REGISTER
Oct 9, 1990 PUBO A PUBLISHED FOR OPPOSITION
Sep 8, 1990 NPUB O NOTICE OF PUBLICATION
Aug 8, 1990 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 23, 1990 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 24, 1990 CNRT F NON-FINAL ACTION MAILED
Jan 8, 1990 DOCK D ASSIGNED TO EXAMINER

Detailed Classifications

Class 042
PHARMACEUTICAL RESEARCH
First Use Anywhere: May 3, 1989
First Use in Commerce: May 3, 1989

Classification

International Classes
042